Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02005614 · ClinicalTrials.gov registry record · NA
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02005614 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 39 participants.
The verdict
NCT02005614, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to collect prospective data for use as a comparator for future subsequent studies attempting to increase the efficacy or reduce the toxicity of gamma knife radiosurgery.
Interventions
- PROCEDURE Gamma Knife Radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2013-11 |
| Est. Completion | 2018-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02005614
The ClinicalTrials.gov registry entry for NCT02005614 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gamma Knife Radiosurgery is the first listed.
NCT02005614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02005614 about?
NCT02005614 is a clinical study titled "A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection". The purpose of this study is to collect prospective data for use as a comparator for future subsequent studies attempting to increase the efficacy or reduce the toxicity of gamma knife radiosurgery.
What is the current status of trial NCT02005614?
This trial is currently terminated. It is a NA study. The enrollment target is 39 participants. The study started on 2013-11. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02005614?
The interventions under investigation include: Gamma Knife Radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT02005614?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.